Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
Retension Pharmaceuticals, Inc.
13G
76135H100
|
8.3% |
10/16/2026
Event 10/9/2026
|